Artificial Tears Market to Reach USD 4.30 Billion by 2027; Increasing Knowledge about Conjunctivitis and Other Eye Disorders to Foster Growth, states Fortune Business Insights™

Key Companies Covered are Allergan, Santen Pharmaceutical Co., Ltd., Bausch & Lomb, Alcon, Novartis AG, Akorn Inc., Eyevance Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Johnson & Johnson, Bayer AG, Otsuka Pharmaceutical Co., Ltd. and other key market players.


Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The global artificial tears market size is expected to reach USD 4.30 billion by 2027, exhibiting a CAGR of 5.9% during the forecast period. The growing incidence of ocular diseases can be a vital factor amplifying the growth of the global market, states Fortune Business Insights, in a report, titled “Artificial Tears Market Size, Share & COVID-19 Impact Analysis, By Type (Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG), Cellulose, and Others), By Delivery (Eye Drops, and Ointments), By Application (Dry Eye Syndrome, Allergies & Infections, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2020-2027.” The market size stood at USD 2.64 billion in 2019.

The artificial tears market encompasses:

  • Wide-ranging analysis of the market
  • Valuable insights into the regions
  • Key market trends and drivers
  • Severe impact of COVID on the industry
  • High-end data about prominent players



Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/artificial-tears-market-103486



Market Driver
:

Introduction of Technologically Advanced Products to Bolster Growth

The constant efforts of eminent players to launch advanced and sophisticated products are expected to have a tremendous effect on the market. For instance, SYSTANE released a variety of products such as Systane® Complete, Systane® Ultra Lubricant Eye Drops, Systane® Balance Lubricant Eye Drops, Systane® Ultra Lubricant Eye Drops, Systane® Preservative-Free Lubricant Eye Drops, Systane® Nighttime Ointment, Systane® Day & Night Lubricant Eye Drop and others. The increasing awareness among the patient population will contribute positively to the growth of the market during the forecast period. The rising cases of dry eye syndrome and conjunctivitis will spur the demand for artificial tears, which, in turn, will boost the market.

The coronavirus has majorly disturbed businesses working across various sectors. The restriction on transportation has limited the supply of products. Moreover, the government of several countries has initiated lockdown to prevent the spread of this infectious disease. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.


To get to know more about the short-term and long-term impacts of COVID-19 on this market,

please visit:
https://www.fortunebusinessinsights.com/artificial-tears-market-103486



Ease on
OTC Products to Offer Impetus to Market During COVID-19

The coronavirus pandemic has severely affected various industries across the globe. The implementation of lockdown by governments has to lead to the disruption of the supply chain. However, the facility for non-essential medical products will improve the prospects of the market during the pandemic. The ease on over the counter (OTC) products such as artificial tears can further aid the speedy expansion of the market. The demand for teardrops in online pharmacies will subsequently propel the growth of the market.

Regional Analysis:

Presence of Eminent Players to Promote Business in North America

The market size in North America stood at USD 1.38 billion in 2019. The growth in North America is attributed to the robust healthcare infrastructure. The growing demand for sophisticated artificial tears will enable the growth of the market. The presence of key market players will influence growth in the region. The increasing prevalence of dry eye syndrome and other ocular diseases such as eye allergies will create lucrative business opportunities for the market.

As per the survey conducted by National Health and Wellness in 2013, it was estimated that up to 6.8% of the population in the U.S. was to be affected by dry eye syndrome. The large patient population is likely to accelerate revenue in North America. The market in Asia Pacific is expected to witness a rapid growth rate during the forecast period due to the growing awareness about ocular diseases. The increasing patient population and healthcare expenditure will foster the healthy growth of the market in the region. The Middle and East and Africa are predicted to account for a significant share in the global market due to the enriching economic conditions and improved healthcare systems.



Quick Buy -  Artificial Tears Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/103486



Notable Development
:

October 2019: Allergan released a new product line called Refresh Relieva lubricant eye.  The launch of the novel product will help the company retain its position in the eye drop industry.

List of the Leading Companies Operating in the Artificial Tears Market are:

  • Allergan (AbbVie Inc.) (Dublin, Ireland)
  • Santen Pharmaceutical Co., Ltd. (Osaka, Japan)
  • Bausch & Lomb (Laval, Canada)
  • Alcon (Geneva, Switzerland)
  • Novartis AG (Basel, Switzerland)
  • Akorn Inc. (Lake Forest, U.S.)
  • Eyevance Pharmaceuticals LLC (Forth Worth, U.S.)
  • Sun Pharmaceutical Industries Ltd. (Mumbai, India)
  • Johnson & Johnson (New Brunswick, U.S.)
  • Bayer AG (Leverkusen, Germany)
  • Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)
  • Other Players



Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/artificial-tears-market-103486



Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Dry Eye Disease - By Key Countries
    • Prevalence of Conjunctivitis - By Key Countries
    • Pipeline Analysis
    • Key Industry Developments
    • New Product Launches
    • Regulatory Scenario - By Key Countries
    • Reimbursement Scenario - By Key Countries
    • R&D Advancements in Artificial Tears
  • Global Artificial Tears Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)
      • Cellulose
      • Others
    • Market Analysis, Insights and Forecast – By Delivery
      • Eye Drops
      • Ointments
    • 5.4 Market Analysis, Insights and Forecast – By Application
      • Dry Eye Syndrome
      • Allergies & Infections
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Drug Stores & Retail Pharmacies
      • Online Pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!



Get your Customized Research Report:
https://www.fortunebusinessinsights.com/enquiry/customization/artificial-tears-market-103486



Have a Look at Related Reports:

Ophthalmic Disease Therapeutics Market Share and Global Trend By Disease Indication (Glaucoma, Retinal Diseases, Dry Eye Disease, Allergy & Infections), By Drug Class (Anti-inflammatory, Anti-infectives, Anti-VEGF, Anti-glaucoma), By Dosage Form (Solid, Liquid, Semi-solid), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Geography Forecast till 2026

Ophthalmic Devices Market Share & Industry Analysis, By Product Type (Ophthalmic Surgical Devices, Ophthalmic Diagnostic Devices, and Vision Care Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026

Dry Eye Syndrome Market Share & Industry Analysis, By Product (Anti-inflammatory and, Artificial Tears and Lubricants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2019-2026

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release:  https://www.fortunebusinessinsights.com/press-release/global-artificial-tears-market-10180